WGS
WGS
NASDAQ · Health Care

Genedx Holdings Corp

$69.34
+0.70 (+1.02%)
As of Nov 4, 10:00 PM ET ·
Financial Highlights (FY 2026)
Revenue
515.15M
Net Income
-25,327,513
Gross Margin
69.7%
Profit Margin
-4.9%
Rev Growth
+22.1%
D/E Ratio
0.23
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 69.7% 69.7% 62.2% 62.2%
Operating Margin -3.1% -2.8% 14.8% 14.6%
Profit Margin -4.9% -4.7% 14.8% 14.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 515.15M 421.80M 1.18B 1.24B
Gross Profit 359.26M 294.16M 732.20M 774.12M
Operating Income -15,763,495 -11,616,429 174.02M 181.42M
Net Income -25,327,513 -18,664,342 173.63M 181.68M
Gross Margin 69.7% 69.7% 62.2% 62.2%
Operating Margin -3.1% -2.8% 14.8% 14.6%
Profit Margin -4.9% -4.7% 14.8% 14.6%
Rev Growth +22.1% +22.1% -3.2% +14.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 211.35M 211.35M 881.91M 877.23M
Total Equity 923.72M 923.72M 1.15B 1.20B
D/E Ratio 0.23 0.23 0.77 0.73
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -10,653,499 -8,286,927 205.84M 224.41M
Free Cash Flow — — 141.12M 137.36M